10x Insights
Loading account…
Companies / Health Care / McKesson Corporation
MCK

McKesson Corporation

Health CareWholesaleS&P 500
Ticker MCKIRVING, TXFiscal year ends MarchBook value per share $-35.57Diluted shares 119.2M

McKesson Corporation (NYSE: MCK) distributes pharmaceuticals and healthcare products and provides related services and technology to pharmacies, healthcare providers, manufacturers, payors and patients in the United States and Canada. Its four reportable segments are North American Pharmaceutical, which distributes… From the company’s description.

In fiscal 2026, McKesson Corporation reported revenue of $403.43B, up 12.4% from fiscal 2025, and net income of $5.10B. Its operating margin was 1.5%, and operations generated $6.16B in cash. Over the twelve months to Jun 30, 2026, revenue was $410.98B.

Fiscal year 2026 · ends 03-31Changes are against fiscal 2025The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$403.43BFY2026
+12.4% year over year
Last 12 mo $410.98B
1.54%FY2026
+0.3 percentage points
Last 12 mo 1.58%
$5.10BFY2026
+46.5% year over year
Last 12 mo $5.30B
-228.52%FY2026
−58.6 percentage points
Last 12 mo -108.30%
Cash & financing
$6.16BFY2026
+1.2% year over year
Last 12 mo $6.85B
$5.41BFY2026
+3.5% year over year
Last 12 mo $6.14B
-3.00FY2026
Was -2.73× a year earlier
Last 12 mo -2.29
124.1MFY2026
−3.1% year over year
Last 12 mo 119.2M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What McKesson Corporation does

In the company’s own words

McKesson Corporation (NYSE: MCK) distributes pharmaceuticals and healthcare products and provides related services and technology to pharmacies, healthcare providers, manufacturers, payors and patients in the United States and Canada. Its four reportable segments are North American Pharmaceutical, which distributes branded, generic, specialty, biosimilar and over-the-counter drugs; Oncology & Multispecialty, which supports specialty practices through drug distribution, practice services, technology, research and cancer-care networks; Prescription Technology Solutions, which connects patients and healthcare stakeholders through medication-access, affordability and adherence services; and Medical-Surgical Solutions, which supplies medical-surgical products, laboratory equipment and related logistics and services to non-acute providers. The company’s portfolio includes Health Mart pharmacies, Canadian banners such as IDA and Guardian, the U.S. Oncology Network, Ontada and INVIVA infusion clinics. McKesson had more than 43,000 employees worldwide as of March 31, 2026, and Medical-Surgical Solutions serves more than 336,000 customers. Its website is www.mckesson.com.

Company details
Sector
Health Care
Industry (SIC)
Wholesale
Headquarters
IRVING, TX
Fiscal year end
March
CIK
927653
SIC
5122

Financial performance, year by year

Fiscal 2014–2026 · USD
$-45.87B$78.72B$203.32B$327.92B$452.52B2014201520162017201820192020202120222023202420252026Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns McKesson Corporation — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

1.0K
funds hold it
1 of 35
superinvestors hold it
$26.83B
held by funds, at market
30.1%
of shares held by funds
13
bond issues held by funds

Superinvestors in McKesson Corporation · what they did last quarter

Stephen MandelDECREASED -85.3%
Lone Pine Capital
0.3%of 13F portfolio

Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.

Largest fund holders · McKesson Corporation’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.13%of fund net assets
VANGUARD 500 INDEX FUND
VOO · VANGUARD INDEX FUNDS
0.14%of fund net assets
iShares Core S&P 500 ETF
IVV · iShares Trust
0.14%of fund net assets
Fidelity 500 Index Fund
FXAIX · Fidelity Concord Street Trust
0.14%of fund net assets
MFS Value Fund
MEIAX · MFS SERIES TRUST I
2.28%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

McKesson Corporation’s bonds, as funds hold them

Funds report holding 13 issues of McKesson Corporation’s debt, $751.41M at market value — what funds hold, not the company’s total debt. Weighted-average coupon 4.77%, maturing 2026 to 2044.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do McKesson Corporation and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of McKesson Corporation's earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in McKesson Corporation's last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.